Looking for experts in evidence mapping, guideline reviews, and evidence synthesis to support a WHO project on delirium in older adults.

Remote assignment (Oct-Dec 2026).

Interested? Contact me directly. Please share.

#Delirium #Geriatrics #EvidenceSynthesis #WHO

Restrict a rapid review to the usual databases and relative recall quietly decides which trials you never see. Topic-specific sources change the answer. https://www.mattheneus.com/editorial/rapid-review-database-restriction-relative-recall-topic-specific-databases-2026-09-24 #HTA #EvidenceSynthesis

27 statements on adult airway management. One high certainty. The rest are expert consensus in guideline clothing. https://www.mattheneus.com/editorial/has-adult-airway-management-operating-theatre-label-recommendation-2026-09-23 #HTA #EvidenceSynthesis

Cochrane endorses INSPECT-SR: 21 checks to screen randomised trials for trustworthiness before they enter your evidence base. https://www.mattheneus.com/editorial/cochrane-inspect-sr-trial-trustworthiness-tool-systematic-reviews-2026-09-24 #HTA #EvidenceSynthesis

Stacked systematic reviews can recycle the same primary studies into one AI accuracy claim. https://www.mattheneus.com/editorial/artificial-intelligence-accuracy-umbrella-review-primary-study-overlap-2026-09-24 #HTA #EvidenceSynthesis

EU coordination group discontinues a joint clinical assessment over unmet dossier information requirements. https://www.mattheneus.com/editorial/european-commission-joint-assessment-discontinued-information-conformity-2026-09-16 #HTA #EvidenceSynthesis #RegulatoryAffairs

Reference prices drive a 69 percent cost gap between two European economic evaluations. https://www.mattheneus.com/editorial/reference-prices-cost-analysis-transferability-economic-evaluation-2026-09-24 #HTA #HealthEconomics #EvidenceSynthesis

Day 1 of #JBIiGNITE is a wrap, and the sparks are still flying!

Today we lit the spark. Tomorrow, we keep the fire burning. See you for Day 2! 🔥

#EvidenceSynthesis #impsci

Rituximab vs ocrelizumab in relapsing MS: high certainty on lesions, very low on relapse. Wrong way round for a cost-substitution call. https://www.mattheneus.com/editorial/rituximab-ocrelizumab-design-stratified-evidence-cost-substitution-2026-09-23 #HTA #EvidenceSynthesis

This article discusses some of the distinctions among different tool structures and approaches for risk of bias assessment and the implications of these approaches for systematic reviewers:
https://ow.ly/UlNm50Yq2nB

#JBImethodology #EvidenceSynthesis

Writing inclusion and exclusion criteria? Four that most reviews need, two that depend on your question, and what to leave out. Examples from education, HR, supply chain and AI.

#SystematicReview #EvidenceSynthesis #AcademicSky

Europe narrows ipidacrine indications after reviewing legacy evidence, underscoring why old evidence bases still demand modern scrutiny. #HTA #EvidenceSynthesis #RegulatoryAffairs https://www.mattheneus.com/editorial/ema-ipidacrine-indication-restrictions-legacy-evidence-review-2026-09-17

#WCQR2027 Training Day | Limited Seats ⏰
In this advanced short course, Dr. King Costa challenges participants to rethink how we judge quality in #QualitativeInquiry

🗓 Feb 1, 2027 | Online (Afternoon)

Secure your place 👇
wcqr.ludomedia.org/training-day/

#QualitativeResearch #AI #EvidenceSynthesis

Poland conditionally backed subcutaneous Vyvgart after reviewing direct and indirect comparative evidence. #HTA #EvidenceSynthesis #RegulatoryAffairs https://www.mattheneus.com/editorial/aotmit-vyvgart-subcutaneous-gmg-conditional-reimbursement-adapt-sc-bucher-2026-09-18

Six trials still leave T-tube use in liver-transplant biliary reconstruction without a clear practice conclusion. #HTA #EvidenceSynthesis #RegulatoryAffairs https://www.mattheneus.com/editorial/cochrane-t-tube-liver-transplant-biliary-reconstruction-six-trials-2026-09-22

Cochrane finds no clear reduction in anastomotic leakage from transanal tubes after rectal cancer surgery. #HTA #EvidenceSynthesis #HealthEconomics https://www.mattheneus.com/editorial/cochrane-transanal-tube-rectal-cancer-leakage-stoma-subgroup-2026-09-22

Modern radiotherapy evaluations need three separate lenses: reporting, bias and uncertainty. https://www.mattheneus.com/editorial/modern-radiotherapy-economic-evaluation-three-dimension-review-2026-09-22 #HTA #HealthEconomics #EvidenceSynthesis

A 4,003-patient network meta-analysis links intravascular imaging to fewer coronary events in calcified lesions. https://www.mattheneus.com/editorial/pubmed-intravascular-imaging-calcified-coronary-lesions-network-meta-analysis-2026-09-17 #HTA #NMA #EvidenceSynthesis #Pharma

Before a tissue-engineered dialysis graft reaches market, price the interventions it must prevent. https://www.mattheneus.com/editorial/tissue-engineered-dialysis-graft-intervention-threshold-early-economic-evaluation-2026-09-21 #HTA #HealthEconomics #EvidenceSynthesis

An ICU cost review arrived already outdated. See why evidence cutoffs matter for remifentanil versus fentanyl decisions. https://www.mattheneus.com/editorial/remifentanil-fentanyl-icu-economic-evidence-update-search-cutoff-2026-09-22 #HTA #HealthEconomics #EvidenceSynthesis